Literature DB >> 10750465

PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.

M Greiver1, N Rosen.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10750465      PMCID: PMC1231271     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  17 in total

Review 1.  Prostate cancer: 3. Individual risk factors.

Authors:  R P Gallagher; N Fleshner
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

Review 2.  Prostate cancer: 2. Natural history.

Authors:  R K Nam; M A Jewett; M D Krahn
Journal:  CMAJ       Date:  1998-09-22       Impact factor: 8.262

Review 3.  Prostate cancer: 4. Screening.

Authors:  F Meyer; Y Fradet
Journal:  CMAJ       Date:  1998-10-20       Impact factor: 8.262

Review 4.  Prostate cancer: 5. Diagnostic tools for early detection.

Authors:  P I Karakiewicz; A G Aprikian
Journal:  CMAJ       Date:  1998-11-03       Impact factor: 8.262

Review 5.  Prostate cancer: 7. Radiation therapy for localized disease.

Authors:  P Warde; C Catton; M K Gospodarowicz
Journal:  CMAJ       Date:  1998-12-01       Impact factor: 8.262

6.  Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer.

Authors:  H B Carter; J I Epstein; D W Chan; J L Fozard; J D Pearson
Journal:  JAMA       Date:  1997-05-14       Impact factor: 56.272

Review 7.  Screening for prostate cancer with prostate-specific antigen. An examination of the evidence.

Authors:  S H Woolf
Journal:  N Engl J Med       Date:  1995-11-23       Impact factor: 91.245

Review 8.  Practice-based small-group CME.

Authors:  J Premi; S Shannon; K Hartwick; S Lamb; J Wakefield; J Williams
Journal:  Acad Med       Date:  1994-10       Impact factor: 6.893

9.  Age-specific reference ranges for serum prostate-specific antigen in black men.

Authors:  T O Morgan; S J Jacobsen; W F McCarthy; D J Jacobson; D G McLeod; J W Moul
Journal:  N Engl J Med       Date:  1996-08-01       Impact factor: 91.245

Review 10.  Prostate cancer: 1. The descriptive epidemiology in Canada.

Authors:  I G Levy; N A Iscoe; L H Klotz
Journal:  CMAJ       Date:  1998-09-08       Impact factor: 8.262

View more
  2 in total

1.  Prostate cancer screening: should family physicians discuss it with their patients?

Authors:  M Greiver
Journal:  Can Fam Physician       Date:  2000-12       Impact factor: 3.275

2.  PSA screening: the bottom line.

Authors:  M M Elhilali
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.